Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis

Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple Sclerosis

Background: In the human central nervous system (CN), resting astrocytes do not visually show endothelin-1 (ET-1)-like immunoreactivity. In patients with multiple sclerosis (MS), an inflammatory disorder of the CNS, high levels of ET-1 are found in reactive astrocytes in demyelinated plaques. ET-1 m...

Bibliografski detalji
Glavni autori:	Stéphanie Hostenbach, Miguel D’Haeseleer, Ron Kooijman, Jacques De Keyser
Format:	Članak
Jezik:	English
Izdano:	Frontiers Media S.A. 2020-01-01
Serija:	Frontiers in Pharmacology
Teme:	multiple sclerosis endothelin-1 astrocytes cytokines inflammation fluoxetine
Online pristup:	https://www.frontiersin.org/article/10.3389/fphar.2019.01491/full

Slični predmeti

Definition, prevalence and predictive factors of benign multiple sclerosis
od: Tatjana Reynders, i dr.
Izdano: (2017-06-01)

Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentan
od: Stéphanie Hostenbach, i dr.
Izdano: (2019-03-01)

Astrocytic β2-adrenergic receptors and multiple sclerosis
od: Jacques De Keyser, i dr.
Izdano: (2004-03-01)

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
od: Joke Temmerman, i dr.
Izdano: (2023-07-01)

Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in
od: Jeroen Van Schependom, i dr.
Izdano: (2019-12-01)

Endothelin-1 is over-expressed in amyotrophic lateral sclerosis and induces motor neuron cell death
od: Eugenia Ranno, i dr.
Izdano: (2014-05-01)

Early-Onset Creutzfeldt-Jakob Disease Mimicking Immune-Mediated Encephalitis
od: Wietse A. Wiels, i dr.
Izdano: (2018-04-01)

Necroptotic kinases are involved in the reduction of depression-induced astrocytes and fluoxetine’s inhibitory effects on necroptotic kinases
od: Salman Zeb, i dr.
Izdano: (2023-01-01)

Correction to: Detecting neurodegenerative pathology in multiple sclerosis before irreversible brain tissue loss sets in
od: Jeroen Van Schependom, i dr.
Izdano: (2020-01-01)

Short-term CO₂ abatement in the European power sector
od: Delarue, Erik D., i dr.
Izdano: (2009)

Sativex® (nabiximols) cannabinoid oromucosal spray in patients with resistant multiple sclerosis spasticity: the Belgian experience
od: Marie D’hooghe, i dr.
Izdano: (2021-06-01)

Gas Balancing Rules Must Take into account the Trade-off between Offering Pipeline Transport and Pipeline Flexibility in Liberalized Gas Markets
od: Keyaerts, Nico, i dr.
Izdano: (2010)

Cognitive-motor telerehabilitation in multiple sclerosis (CoMoTeMS): study protocol for a randomised controlled trial
od: Delphine Van Laethem, i dr.
Izdano: (2022-09-01)

Automated modelling of signal transduction networks
od: Aach John, i dr.
Izdano: (2002-11-01)

Influence of Motivational Design Techniques on Use and Acceptance of Self-Management Health Systems in Older Adults
od: Ine D’Haeseleer, i dr.
Izdano: (2022-03-01)

Recognition of Bathroom Activities in Older Adults Using Wearable Sensors: A Systematic Review and Recommendations
od: Yiyuan Zhang, i dr.
Izdano: (2021-03-01)

Spontaneously hypertensive rats display reduced microglial activation in response to ischemic stroke and lipopolysaccharide
od: De Geyter Deborah, i dr.
Izdano: (2012-05-01)

Transporter annotations are holding up progress in metabolic modeling
od: John Casey, i dr.
Izdano: (2024-07-01)

Combining multiple functional annotation tools increases coverage of metabolic annotation
od: Marc Griesemer, i dr.
Izdano: (2018-12-01)

Endothelins: Vasoactive Peptids
od: Hasan Erdoğan, i dr.
Izdano: (2013-08-01)

Disrupted working memory event-related network dynamics in multiple sclerosis
od: Chiara Rossi, i dr.
Izdano: (2024-11-01)

Role of endothelin-1 in periodontal diseases: A structured review
od: Waleed Khalid, i dr.
Izdano: (2016-01-01)

Increased brain atrophy and lesion load is associated with stronger lower alpha MEG power in multiple sclerosis patients
od: Jeroen Van Schependom, i dr.
Izdano: (2021-01-01)

On physics of a hypothetical core disruptive accident in Multipurpose hYbrid Research Reactor for High-tech Applications – MYRRHA
od: Petrović Đorđe, i dr.
Izdano: (2023-01-01)

Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients
od: B. Villaggio, i dr.
Izdano: (2012-12-01)

Insights into Endothelin-3 and Multiple Sclerosis
od: Monti Lucia, i dr.
Izdano: (2020-06-01)

Roles of Astrocytic Endothelin ET<sub>B</sub> Receptor in Traumatic Brain Injury
od: Shotaro Michinaga, i dr.
Izdano: (2023-02-01)

Fluoxetin Upregulates Connexin 43 Expression in Astrocyte
od: Hossein Mostafavi, i dr.
Izdano: (2014-02-01)

Expression of Endothelin-1, Endothelin Receptor-A, and Endothelin Receptor-B in facial melasma compared to adjacent skin
od: da Silva CN, i dr.
Izdano: (2023-10-01)

Brain dysconnectivity relates to disability and cognitive impairment in multiple sclerosis
od: Sjogard, M, i dr.
Izdano: (2020)

Ulinastatin alleviates traumatic brain injury by reducing endothelin-1
od: Liu Ting, i dr.
Izdano: (2020-12-01)

Disrupted working memory event-related network dynamics in multiple sclerosis
od: Rossi, C, i dr.
Izdano: (2024)

Disrupted working memory event-related network dynamics in multiple sclerosis
od: Rossi, C, i dr.
Izdano: (2024)

Shotgun Immunoproteomic Approach for the Discovery of Linear B-Cell Epitopes in Biothreat Agents Francisella tularensis and Burkholderia pseudomallei
od: Patrik D’haeseleer, i dr.
Izdano: (2021-09-01)

The Impact of Cognitive Dysfunction on Locomotor Rehabilitation Potential in Multiple Sclerosis
od: Stijn Denissen, i dr.
Izdano: (2019-11-01)

Endothelins as mediators in the modulation of cardiac performance
od: Smiljić Sonja, i dr.
Izdano: (2014-01-01)

Circulating Levels of Endothelin-1 and Big Endothelin-1 in Patients with Essential Hypertension
od: Krasimir Kostov, i dr.
Izdano: (2021-10-01)

Pharmacological Potential of Endothelin Receptors Agonists and Antagonists
od: Jiří Patočka, i dr.
Izdano: (2005-01-01)

The role of endothelin and RAS/ERK signaling in immunopathogenesis-related fibrosis in patients with systemic sclerosis: an updated review with therapeutic implications
od: Mohsen Rokni, i dr.
Izdano: (2022-05-01)

Sequential astrocytic 5-HT2B receptor stimulation, [Ca2+]i regulation, glycogenolysis, glutamate synthesis and K+ homeostasis are similar but not identical in learning and mood regulation
od: Ye eChen, i dr.
Izdano: (2016-01-01)